SEC Form D filing
Rapalogix Health, Inc.
Biotech · Series B · Regulation D 506(b) · CA · Filed June 26, 2026
- Offering amount
- $25.0M
- Exemption
- Reg D 506(b)
- Issuer state
- CA
- Filing date
- June 26, 2026
- Signature date
- June 25, 2026
- CIK
- 0002008372
Summary
Auto-generatedRapalogix Health, Inc. (CA) raised ~$25M under 506(b). 'Rapalogix' suggests a biotech/pharma company (rapamycin-related); amount anchors series-b stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.